Minister of economic affairs-
designate Lee Chih-kung (李世光) yesterday compared the impact of the OBI Pharma Inc (台灣浩鼎) controversy on the nation’s biotechnology industry to a “tsunami.”
OBI Pharma “definitely has an influence” on the biotech industry, Lee said during an interview with radio host Clara Chou (周玉蔻).
Photo: Huang Pei-chun, Taipei Times
“The impact looks like the beginning of a tsunami,” he added.
Lee said it was hard to say how long it would take for the industry to recover from the scandal, sparked by allegations of insider trading and conflict of interest at OBI Pharma, adding that it would depend on public sentiment.
Most developed countries value the biotech industry and understand that it requires long-term investment, he said.
“I am not trying to speak for OBI Pharma. The insider trading and conflict of interest allegations are indeed significant issues, but I think the public should seek the truth and look at the matter rationally,” Lee told reporters after the interview.
Lee declined to comment on Academia Sinica President Wong Chi-huey’s (翁啟惠) role in the case, saying that Wong should explain the matter to the public.
Wong is an internationally renowned academic, Lee said, adding that he does not think Wong’s involvement in the controversy is a “shame.”
However, the scandal and its effect on the public have affected the reputation of Academia Sinica, he said.
Local media reports have also revealed that Lee’s younger brother, Howard Lee (李世仁), is an independent board member of OBI Pharma and a member of Academia Sinica’s research and development results management committee — sparking a new round of speculation about conflict of interest.
C.K. Lee said that his brother’s situation cannot be classified as a conflict of interest, because the committee does not deal with individual companies.
Moreover, his brother does not receive remuneration as committee member, only a transportation allowance of NT$1,000 to NT$2,000 each time, C.K. Lee said.
However, he has asked his brother to consider resigning from OBI Pharma and the committee given his ministry post.
C.K. Lee also confirmed that he has dual citizenship, but said he had submitted an application to the American Institute in Taiwan (AIT) to give up his US citizenship, with an interview scheduled next week.
C.K. Lee, who is to take up his new post on May 20, is to visit Minister of Economic Affairs John Deng (鄧振中) on Monday to talk about the handover, the ministry said.
The 56-year-old said his biggest challenges in his new post would be finding ways to boost economic development, increase wages for young people and attract international talent to Taiwan.
His first task when he assumes office will be to promote development of the green energy sector in Taiwan in the hope of building a demand-oriented industry as soon as possible, Lee said.
He said he will also push for reform of the industrial sector, which has complained of water, electricity, land, and labor shortages.
Lee said he was made aware of the problems during his tour on April 28 of various industrial and commercial enterprises, which also mentioned other problems such as limited access to funding and consultancy services.
Additional reporting by CNA
RUN IT BACK: A succesful first project working with hyperscalers to design chips encouraged MediaTek to start a second project, aiming to hit stride in 2028 MediaTek Inc (聯發科), the world’s biggest smartphone chip supplier, yesterday said it is engaging a second hyperscaler to help design artificial intelligence (AI) accelerators used in data centers following a similar project expected to generate revenue streams soon. The first AI accelerator project is to bring in US$1 billion revenue next year and several billion US dollars more in 2027, MediaTek chief executive officer Rick Tsai (蔡力行) told a virtual investor conference yesterday. The second AI accelerator project is expected to contribute to revenue beginning in 2028, Tsai said. MediaTek yesterday raised its revenue forecast for the global AI accelerator used
TEMPORARY TRUCE: China has made concessions to ease rare earth trade controls, among others, while Washington holds fire on a 100% tariff on all Chinese goods China is effectively suspending implementation of additional export controls on rare earth metals and terminating investigations targeting US companies in the semiconductor supply chain, the White House announced. The White House on Saturday issued a fact sheet outlining some details of the trade pact agreed to earlier in the week by US President Donald Trump and Chinese President Xi Jinping (習近平) that aimed to ease tensions between the world’s two largest economies. Under the deal, China is to issue general licenses valid for exports of rare earths, gallium, germanium, antimony and graphite “for the benefit of US end users and their suppliers
Dutch chipmaker Nexperia BV’s China unit yesterday said that it had established sufficient inventories of finished goods and works-in-progress, and that its supply chain remained secure and stable after its parent halted wafer supplies. The Dutch company suspended supplies of wafers to its Chinese assembly plant a week ago, calling it “a direct consequence of the local management’s recent failure to comply with the agreed contractual payment terms,” Reuters reported on Friday last week. Its China unit called Nexperia’s suspension “unilateral” and “extremely irresponsible,” adding that the Dutch parent’s claim about contractual payment was “misleading and highly deceptive,” according to a statement
Artificial intelligence (AI) giant Nvidia Corp’s most advanced chips would be reserved for US companies and kept out of China and other countries, US President Donald Trump said. During an interview that aired on Sunday on CBS’ 60 Minutes program and in comments to reporters aboard Air Force One, Trump said only US customers should have access to the top-end Blackwell chips offered by Nvidia, the world’s most valuable company by market capitalization. “The most advanced, we will not let anybody have them other than the United States,” he told CBS, echoing remarks made earlier to reporters as he returned to Washington
RSS